| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Nasus Pharma Ltd.
13G
NSRX · M7071P109
|
6.4% |
8/20/2025
Event 8/14/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.